Adipose Tissue Gene Expression Profiles in Women With Polycystic Ovary Syndrome (PCOS) Versus Controls
1 other identifier
observational
10
1 country
2
Brief Summary
Adipose tissue is a central organ in mediating metabolic health. There is some evidence that women with polycystic ovary syndrome (PCOS) have a degree of adipose tissue dysfunction which may negatively affect their metabolic health. The aim of this study was to assess transcriptomic profiles of subcutaneous adipose tissue of women with PCOS in comparison with a control population matched on the basis of age and body mass index (BMI). A secondary aim was to then relate these gene expression profiles to the biochemical environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2007
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 2, 2010
CompletedFirst Posted
Study publicly available on registry
September 6, 2010
CompletedSeptember 6, 2010
July 1, 2008
7 months
September 2, 2010
September 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Transcriptomic profiling of subcutaneous adipose tissue of women with PCOS and age and BMI matched controls
Gene expression profiles from women with PCOS and controls matched for age and BMI were determined by microarray analysis of whole subcutaneous adipose tissue samples. Single gene changes as well as pathway analyses will be used to determine differently expressed genes and pathways between the PCOS cohort and controls.
Recruitment ran from Dec 2007-July 2008. Subjects attended the study location fasting on one occasion
Secondary Outcomes (1)
Measurement of biomarkers of metabolic health (lipid, inflammatory markers) in plasma of PCOS cases and controls
Recruitment ran from Dec 2007-July 2008. Subjects attended the study location fasting on one occasion
Study Arms (2)
PCOS-CSAT
Women with PCOS
Control-CSAT
Control population consisting of women without PCOS, matched for age and BMI with the PCOS cohort
Eligibility Criteria
Women with PCOS and a control population of women matched for age and body mass index (BMI)
You may qualify if:
- Had a positive diagnosis of PCOS as defined according to the NIH criteria as chronic oligomenorrhoea (\< 9 menstrual cycles per year) and clinical and/or biochemical evidence of hyperandrogenism, in the absence of other disorders causing the same phenotype. Clinical criteria included hirsutism with a Ferriman-Galwey score greater than 9, acne or male pattern alopecia; biochemical criteria included total-testosterone, androstenedione or dehydroepiandrosterone sulphate (DHEAS) greater than the laboratory reference range.
- Were between the ages of 18 and 40
You may not qualify if:
- Were under 18 years or greater than 40 years old,
- Were non-Caucasian
- Were pregnant, lactating or trying to conceive
- Had a body mass index (BMI) \<18kg/m2 or \>50kg/m2
- Had a recent illness or any chronic illness likely to influence results
- Were taking hormonal contraception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Adelaide and Meath Hospitallead
- University College Dublincollaborator
Study Sites (2)
Diabetes Day Centre, The Adelaide and Meath Hosptial
Dublin, Dublin, 24, Ireland
Nutrigenomics Group, University College Dublin
Dublin, Leinster, Dublin 4, Ireland
Biospecimen
Plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Gibney, Dr
The Adelaide and Meath Hospital
- PRINCIPAL INVESTIGATOR
Helen M Roche, Dr
University College Dublin
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 2, 2010
First Posted
September 6, 2010
Study Start
December 1, 2007
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
September 6, 2010
Record last verified: 2008-07